Literature DB >> 28322937

Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.

Takumi Tomono1, Kentaro Yano2, Takuo Ogihara3.   

Abstract

Overexpression and activation of P-glycoprotein (P-gp), which mediates efflux transport of various anticancer drugs in cancer cells, is associated with multidrug resistance (MDR). On the other hand, malignant cancer cells frequently undergo epithelial-to-mesenchymal transition (EMT), thereby acquiring high migratory mobility and invasive ability. Snail is a transcriptional factor that represses multiple other factors, and its overexpression is a trigger of EMT. Because both P-gp and Snail are involved in malignant evolution of cancer, in this work, we evaluated whether EMT induced by overexpression of Snail influences P-gp expression and activity. Snail-overexpressing cells showed downregulation of epithelial markers, E-cadherin, occludin, and claudin-1, and upregulation of mesenchymal markers, vimentin and ZEB1. Although Western blot analysis showed that P-gp expression levels were similar in Mock and Snail-overexpressing cells, the results of P-gp functional assays with P-gp substrates rhodamine123 and paclitaxel indicated that P-gp is activated in Snail-overexpressing cells. Indeed, Snail-overexpressing cells showed greater viability than Mock cells in the presence of paclitaxel. We observed caveolin-1 dephosphorylation and decreased growth factor receptor-bound protein 2 (GRB2) expression in Snail-overexpressing cells. These findings suggest a novel pathway leading to cancer MDR, in which Snail induces EMT concomitantly with a decrease in GRB2-mediated caveolin-1 phosphorylation, resulting in activation of P-gp.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  P-glycoprotein; cancer; cancer chemotherapy; drug resistance; efflux pumps; membrane transporter; multidrug resistance transporters

Mesh:

Substances:

Year:  2017        PMID: 28322937     DOI: 10.1016/j.xphs.2017.03.011

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer.

Authors:  Chunhua Chen; Shiheng Li; Junli Xue; Manlong Qi; Xin Liu; Yan Huang; Jinghua Hu; Haidong Dong; Kun Ling
Journal:  JCI Insight       Date:  2021-04-22

2.  ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance.

Authors:  Bruno C Gomes; Mónica Honrado; Ana Armada; Miguel Viveiros; José Rueff; António S Rodrigues
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

3.  Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin.

Authors:  M Hunter Joyce; Carolyne Lu; Emily R James; Rachel Hegab; Shane C Allen; Laura J Suggs; Amy Brock
Journal:  Front Oncol       Date:  2018-09-05       Impact factor: 6.244

4.  Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells.

Authors:  Takumi Tomono; Tatsuya Machida; Hiroki Kamioka; Yumi Shibasaki; Kentaro Yano; Takuo Ogihara
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

5.  Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition.

Authors:  Zhenlv Lin; Lin Zhang; Junfeng Zhou; Jiantao Zheng
Journal:  Mol Med Rep       Date:  2019-08-21       Impact factor: 2.952

6.  The expression and clinical significance of murine double minute 2, lysosome-associated membrane protein 1, and P-glycoprotein in pediatric acute lymphoblastic leukemia.

Authors:  Zhuoyu Wen; Hui Li; Juan Zhang
Journal:  Transl Pediatr       Date:  2020-10

Review 7.  The role of epithelial-mesenchymal transition-regulating transcription factors in anti-cancer drug resistance.

Authors:  Jihye Seo; Jain Ha; Eunjeong Kang; Sayeon Cho
Journal:  Arch Pharm Res       Date:  2021-03-25       Impact factor: 4.946

Review 8.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

9.  E-cadherin-Fc chimera protein matrix enhances cancer stem-like properties and induces mesenchymal features in colon cancer cells.

Authors:  Yamin Qian; Xin Wu; Yuhki Yokoyama; Daisuke Okuzaki; Mai Taguchi; Haruka Hirose; Jiaqi Wang; Tsuyoshi Hata; Akira Inoue; Masayuki Hiraki; Masahisa Ohtsuka; Hidekazu Takahashi; Naotsugu Haraguchi; Tsunekazu Mizushima; Shinji Tanaka; Masaki Mori; Hirofumi Yamamoto
Journal:  Cancer Sci       Date:  2019-09-30       Impact factor: 6.716

10.  The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis.

Authors:  Natalia I Díaz-Valdivia; Jorge Díaz; Pamela Contreras; América Campos; Victoria Rojas-Celis; Renato A Burgos-Ravanal; Lorena Lobos-González; Vicente A Torres; Viviana I Perez; Balz Frei; Lisette Leyton; Andrew F G Quest
Journal:  Oncogene       Date:  2020-03-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.